The aftermath of childhood hyperthyroidism

M Segni1, C A Gorman

  • 1Department of Pediatrics, University La Sapienza, Rome, Italy. m.segni@mclink.it

Insights

Long-term juvenile hyperthyroidism effects are mainly from treatments, not the condition itself. While some symptoms resolve, serious complications like agranulocytosis and surgical risks can occur.

Area of Science:

  • Pediatric Endocrinology
  • Thyroidology

Background:

  • Juvenile hyperthyroidism presents unique challenges in long-term management.
  • Consequences can stem from the hyperthyroid state or its therapeutic interventions.

Purpose of the Study:

  • To delineate the long-term sequelae of juvenile hyperthyroidism.
  • To differentiate between disease-related and treatment-related adverse outcomes.

Main Methods:

  • Review of existing literature on juvenile hyperthyroidism outcomes.
  • Analysis of adverse event data associated with antithyroid drugs, surgery, and radioiodine therapy.

Main Results:

  • Most hyperthyroid symptoms in children resolve with euthyroid state restoration.
  • Permanent adverse effects are primarily linked to treatments: 28% experience mild drug side effects; surgery carries risks of hypoparathyroidism (2%), cord paralysis (2%), and mortality (1/1000).
  • Radioiodine therapy's long-term risks are theoretical, though it can improve ophthalmopathy.

Conclusions:

  • Treatment, not the hyperthyroid state itself, is the primary driver of permanent adverse effects in juvenile hyperthyroidism.
  • Careful consideration of treatment risks is crucial for managing pediatric thyrotoxicosis.
  • Long-term consequences beyond established treatment morbidities remain largely uncharacterized.

Related Concept Videos

Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...